CA Stock MarketDetailed Quotes
PRM Big Pharma Split Corp
- 14.400
- +0.250+1.77%
15min DelayMarket Closed Jul 12 16:00 ET
16.76MMarket Cap-27169P/E (TTM)
14.400High14.320Low900Volume14.320Open14.150Pre Close12.93KTurnover14.40052wk High0.08%Turnover Ratio1.16MShares12.40352wk Low-0.53EPS TTM16.76MFloat Cap14.400Historical HighLossP/E (Static)1.16MShs Float5.228Historical Low-0.53EPS LYR0.57%Amplitude1.24Dividend TTM1.06P/B1Lot Size8.59%Div YieldTTM
Big Pharma Split Corp Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | |
|---|---|---|---|---|---|---|---|
| Total revenue | -91.60%311.76K | -30.76%3.71M | 809.51%5.36M | -83.36%589.26K | -46.96%3.54M | 1,539.72%6.68M | 407.11K |
| Non interest income | -91.60%311.76K | -30.76%3.71M | 809.51%5.36M | -83.36%589.26K | --3.54M | ---- | --407.11K |
| -Fees and commissions | 27.33%-230.49K | -21.02%-317.15K | -31.10%-262.06K | 16.08%-199.9K | ---238.19K | ---- | ---27.85K |
| -Dividend income | -29.93%767.35K | 24.78%1.1M | -4.90%877.62K | 1.49%922.88K | --909.32K | ---- | --31.13K |
| Credit losses provision | |||||||
| Non interest expense | |||||||
| Selling and administrative expenses | -6.49%334.55K | -3.46%357.76K | 71.36%370.56K | -21.66%216.25K | -16.85%276.03K | 328.06%331.96K | --77.55K |
| -General and administrative expense | -6.49%334.55K | -3.46%357.76K | 71.36%370.56K | -21.66%216.25K | -16.85%276.03K | 328.06%331.96K | --77.55K |
| Income from associates and other participating interests | |||||||
| Special income (charges) | |||||||
| Other non-operating income (expenses) | |||||||
| Income before tax | -104.44%-139.68K | -35.19%3.15M | 1,728.64%4.85M | -91.56%265.42K | 13.10%3.14M | 760.12%2.78M | 323.22K |
| Income tax | |||||||
| Earnings from equity interest net of tax | |||||||
| Net income | -104.44%-139.68K | -35.19%3.15M | 1,728.64%4.85M | -91.56%265.42K | 13.10%3.14M | 760.12%2.78M | 323.22K |
| Net Income continuous operations | -104.44%-139.68K | -35.19%3.15M | 1,728.64%4.85M | -91.56%265.42K | 13.10%3.14M | 760.12%2.78M | --323.22K |
| Noncontrolling interests | |||||||
| Net income attributable to the company | -104.44%-139.68K | -35.19%3.15M | 1,728.64%4.85M | -91.56%265.42K | 13.10%3.14M | 760.12%2.78M | 323.22K |
| Preferred stock dividends | -33.11%505.67K | 9.99%756.02K | 42.37%687.38K | -14.46%482.81K | -16.41%564.43K | 5.27%675.23K | 641.42K |
| Other under preferred stock dividend | -43.5K | ||||||
| Net income attributable to common stockholders | -127.01%-645.35K | -43.24%2.39M | 2,036.51%4.21M | -108.43%-217.39K | 22.57%2.58M | 761.50%2.1M | -318.2K |
| Diluted earnings per share | -133.54%-0.53 | -51.68%1.58 | 1,586.36%3.27 | -110.19%-0.22 | 38.46%2.16 | 778.26%1.56 | -0.23 |
| Basic earnings per share | -133.54%-0.53 | -51.68%1.58 | 1,586.36%3.27 | -110.19%-0.22 | 38.46%2.16 | 778.26%1.56 | -0.23 |
| Dividend per share | 0.00%1.2372 | 0.00%1.2372 | 0.00%1.2372 | 0.00%1.2372 | 33.33%1.2372 | 0.9279 | |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg